about
A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) PatientsStudy to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + TiotropiumComparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With A Reference ProductEvaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent AsthmaSERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseEffects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary DiseaseSafety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) PatientsEvaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways FunctionEfficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary DiseaseEfficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in ChinaExtension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsTiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator TiotropiumStudy to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsClinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaPredictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPDEffect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPDCharacteristics of Pts Initiating Spiriva Respimat in AsthmaA Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® InhalerEfficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary DiseaseSafety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic FibrosisThe Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseEfficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary DiseaseStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromideJapan Long-term Safety for Tiotropium Plus OlodaterolThe Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 StudyTiotropium in Patients With Tuberculosis (TB) Destroyed LungChronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety PopulationOutcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
P4844
Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitroTriple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treCost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UKSuppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.Efficacy of Tiotropium Bromide and Rehabilitation Treatment on Pulmonary Function of Patients With Sulfur Mustard Lung Injury.Gateways to clinical trialsGateways to clinical trials
P921
Q61707439-1DC8F677-5F75-4717-B654-CF3CACC0374CQ61909439-F0A860AE-BFED-4797-B6D8-F77AC2A12283Q61909679-082A9432-64AF-46CD-BAB5-7435C61BFD5AQ61917484-C60B961F-FC9E-4CF6-8BB7-C1124A6075B5Q61921596-4CF39F38-67F2-4C5F-892A-982BE7E2A3D8Q61921617-E403CFD6-6DA5-4E45-91C0-249C6F85A6E8Q61921766-15F95DFA-EDD8-47AA-B3B9-7A83C7942941Q61934314-59FC873E-E6A4-434D-AA87-30C3ECEBE46EQ61934915-FE57D955-940E-40DD-A318-F12C17981688Q61938572-858A3324-EAFE-446D-B8F1-6B3A1F993421Q61939020-EC80CC05-A568-4F19-8726-39715499A213Q61956283-9F145FD4-AEFE-427B-AFD6-AE13205C5A91Q61956458-EE357982-D8C1-4829-BDA2-A419565BCABCQ61957000-78ECBB36-7584-4CC2-B1F3-7EE8D61749E9Q61966176-E5221C66-8793-4A3D-AECE-BEDE2DEFE450Q61975327-40010904-0B9E-41B0-85C1-927FD41B23FBQ61975412-3F385FD9-B341-4499-A0DC-1A5E6D851930Q61975849-F262E4BE-D99A-4FF7-BB61-A3A18F04D0D7Q61980299-51562711-1B4C-4839-9335-0FCC7A73B6D2Q61980584-552FFE2D-DBD4-4227-BA9C-E65BC3A553D5Q61980608-5675D157-7DBA-477F-8D3B-DB62E6E65A50Q61980829-0C99B1DE-1262-4E2C-9002-0F604120DDDFQ61981128-7817D997-2A3F-41D4-98F5-679B2C4C30ECQ61981453-84F9BE9E-ACA7-4004-B207-18009094B265Q62034513-B31A13D4-E096-4C2E-9753-6CA972AE408CQ62053988-27A03EC4-B6C3-455E-9C69-F10FC28DCA34Q62062140-51C55432-C74D-4AE1-A169-925FDEF16C6EQ62105670-4A0FC0DD-6737-4DCD-A932-507784A7B594Q63063246-B21F9B2A-73D2-4D01-B77A-16A3F7170124Q63315929-408F4AEB-E7BB-41F4-BB4F-458E614C9B71Q63317173-97EDA020-7088-4323-BA3F-D22D77920EB8Q63317761-F98E292B-6D32-4353-9A37-6EB380C454AFQ63317953-913A8116-3301-47FD-95C5-48B919F83D06Q63320408-6A5BD6A1-3171-447B-93F6-AC9D3A04C020Q63320905-DAADB271-27E0-473B-9489-9A240D426B57Q63321235-47B66B2F-267E-4AC1-8F7F-207792AD30A4Q63333772-BD625782-6E6B-4145-8454-6F21B6057606Q63335637-4F329F6F-2C90-45C5-A1CA-79E678936C1FQ63337530-01AF00F1-C502-4B84-B459-D2FE5EBFCE83Q63337927-50B27156-9B57-4C59-A697-1CA98C4F8555
P4844
Q34128938-3087C1CA-D945-45A2-B769-FBC0CE5C7D95Q36265120-A203A899-D33A-4507-8A73-F08A33B0CCF4Q36366132-5097AA88-0100-45C5-94FA-6DE433564416Q37115916-DB322B14-471C-41C9-9C37-690C42E61AA7Q43098120-D616BD74-3682-44B7-A7DE-F883E62F1889Q81632899-06A0C81D-E802-4A84-9C57-CE66A9955589Q84320080-3BFBC025-00A2-4FCC-A3EA-AB71DA4F3420
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Tiotropiumbromid-Anhydrat
@de
tiotropium bromide
@en
tiotropiumbromid
@nn
type
label
Tiotropiumbromid-Anhydrat
@de
tiotropium bromide
@en
tiotropiumbromid
@nn
altLabel
(1alpha,2beta,4beta,5alpha,7be ...... lo[3.3.1.0(2,4)]nonane bromide
@en
7-((Hydroxybis(2-thienyl)acety ...... lo(3.3.1.0(2,4))nonane bromide
@en
BA 679 BR
@en
BA 679BR
@en
BA-679 BR
@en
tiotropium bromide anhydrous
@en
prefLabel
Tiotropiumbromid-Anhydrat
@de
tiotropium bromide
@en
tiotropiumbromid
@nn
P661
P683
P1579
P2017
C[N+]1([C@@H]2C[C@H](C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]
P2067
471.017365
P2275
tiotropium bromide
@en
P231
136310-93-5
P232
P233
C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-]
P234
1S/C19H22NO4S2.BrH/c1-20(2)12- ...... q+1;/p-1/t11-,12-,13+,16-,17+;
P235
DQHNAVOVODVIMG-FOGIBKMMSA-M
P2566
100.205.794
P3117
DTXSID2044214
P3345
P652
XX112XZP0J